Additional phosphoproteomic studies in APP/PS1 models reveal that restoring phosphorylation homeostasis through chemical interventions, such as tetrahydroxy stilbene glycoside, can mitigate AD-related alterations in kinase signaling pathways [58]. This evidence concerns the gene APP and Alzheimer disease.